Pharmaceutical Executive Digest:
Having trouble viewing this e-mail? Click here.

 
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.

Pharmaceutical Executive Europe  E-News  
 
 
 
 
 
 

You can now follow us on Twitter at Twitter.com/pharmexecdigi
 
Survey
We asked 40 pharma leaders, if you were developing a biosimilar, what would be your biggest concern?

Development costs 0%
Safety concerns 43%
Regulatory processes 43%
Legal challenges 14%

Talk to us:
editor@pharmexeceurope.com

Advertise with us: jgray@advanstar.com


2 August, 2011

In this Issue
The US Debt Crisis: An Unwelcome Prescription for Pharma
As the White House and Congress battle to raise the country's debt ceiling, what are the potential implications of the various debt-reduction proposals on the pharmaceutical industry?
More...
India Cracks Down on Substandard Drugs
FDA findings in the State of Maharashtra fuel a new Indian effort to tackle 'spurious' and substandard drugs.
More...
What Can the iPad Bring to Clinical Trials Management?
The iPad can seemingly do anything and everything, but it’s yet to make an impact on the clinical trials industry, writes Wayne Kubick.
More...
EMA Tackle Readability of Packaging Leaflets
Package leaflets will now include ‘less rigid language’ and new sections that provide greater information about a drug’s benefits, as well as information about the medicine’s use in children.
More...

Also in this issue…
10 Pitfalls of Licensing Agreements
Q&A with Almirall's New CEO, Eduardo Sanchiz
Latest Pharma Appointments

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone
numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other
opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.com or by mail

at Advanstar Communications Inc., Bridgegate Pavilion, 4A Chester Business Park, Wrexham Road, Chester, CH4 9QH, UK